Panacea Biotec Limited
NSE:PANACEABIO.NS
513.65 (INR) • At close May 12, 2025
Overview | Financials
Numbers are in millions (except for per share data and ratios) INR.
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 5,591.7 | 4,599.5 | 6,592.23 | 6,176.49 | 5,371.86 | 4,523.36 | 5,860.3 | 5,253.7 | 6,530.8 | 6,871.9 | 5,099.9 | 6,084.9 | 7,100.9 | 11,678.8 | 9,009.5 | 7,881.719 | 8,413.435 | 8,423.543 | 5,419.015 | 3,279.273 |
| Cost of Revenue
| 2,301.26 | 2,526.6 | 3,176.68 | 2,046.31 | 4,035.79 | 2,027.09 | 4,662.45 | 1,714.89 | 2,158.1 | 2,802.1 | 2,283.9 | 5,951.5 | 3,475.7 | 5,863.5 | 4,719.9 | -452.622 | -4.589 | 123.484 | 12.956 | -346.951 |
| Gross Profit
| 3,290.44 | 2,072.9 | 3,415.55 | 4,130.18 | 1,336.07 | 2,496.27 | 1,197.85 | 3,538.81 | 4,372.7 | 4,069.8 | 2,816 | 133.4 | 3,625.2 | 5,815.3 | 4,289.6 | 8,334.342 | 8,418.024 | 8,300.059 | 5,406.059 | 3,626.224 |
| Gross Profit Ratio
| 0.588 | 0.451 | 0.518 | 0.669 | 0.249 | 0.552 | 0.204 | 0.674 | 0.67 | 0.592 | 0.552 | 0.022 | 0.511 | 0.498 | 0.476 | 1.057 | 1.001 | 0.985 | 0.998 | 1.106 |
| Reseach & Development Expenses
| 0 | 139.13 | 105.09 | 125.62 | 0 | 157.73 | 144.6 | 79.53 | 83 | 83.2 | 86.2 | 0 | 0 | 753.1 | 753.063 | 669.944 | 410.508 | 395.111 | 280.926 | 140.562 |
| General & Administrative Expenses
| 295.26 | 158.4 | 276.71 | 274.67 | 202.59 | 239.76 | 229.9 | 216.64 | 263.8 | 277.5 | 298.5 | 420.7 | 884.7 | 844.5 | 0 | 0 | -9.513 | 4,287.117 | 3,194.865 | 2,265.726 |
| Selling & Marketing Expenses
| 285.24 | 427.05 | 480.84 | 511.81 | 428.08 | 312.65 | 369.83 | 377 | 350.8 | 330.9 | 460.9 | 488.7 | 576.5 | 481.5 | 474.656 | 458.23 | 492.3 | 342.398 | 251.151 | 203.908 |
| SG&A
| 580.5 | 585.45 | 757.55 | 786.48 | 928.9 | 997.5 | 599.73 | 593.64 | 614.6 | 608.4 | 759.4 | 909.4 | 1,461.2 | 1,326 | 474.656 | 458.23 | 482.787 | 4,629.514 | 3,446.017 | 2,469.634 |
| Other Expenses
| 2,691.49 | -66.88 | 3,071.06 | 0 | -90.49 | -53.36 | 5.11 | 3,432.84 | 3,864.4 | 4,372.3 | 3,839.4 | 0 | 4,717.2 | 1,720.3 | 1,499.7 | 7,722.862 | 5,354.637 | 983.774 | 551.524 | 478.945 |
| Operating Expenses
| 3,271.99 | 2,838.15 | 3,933.7 | 3,523.96 | 1,756.31 | 2,496.27 | 3,628.97 | 4,106.01 | 4,562 | 5,063.9 | 3,925.6 | 5,981.4 | 6,178.4 | 3,799.4 | 2,727.6 | 8,334.342 | 6,388.793 | 6,008.399 | 4,278.467 | 3,089.14 |
| Operating Income
| -442.22 | -1,056.54 | -518.15 | 427.33 | 429.26 | -1,118.93 | 410.46 | -567.2 | -189.3 | -994.1 | -1,109.6 | -2,530.6 | -2,553.2 | 2,015.9 | 1,556.132 | -516.695 | 2,028.398 | 2,291.66 | 1,127.592 | 537.084 |
| Operating Income Ratio
| -0.079 | -0.23 | -0.079 | 0.069 | 0.08 | -0.247 | 0.07 | -0.108 | -0.029 | -0.145 | -0.218 | -0.416 | -0.36 | 0.173 | 0.173 | -0.066 | 0.241 | 0.272 | 0.208 | 0.164 |
| Total Other Income Expenses Net
| 456.99 | 1,184.59 | 15,011.71 | -1,869.79 | -2,141.46 | 1,605.08 | -1,047.81 | 48.42 | 0 | 0 | 0 | 0 | 0 | -472.2 | -428.424 | -379.362 | -152.373 | -173.102 | -140.75 | -134.623 |
| Income Before Tax
| 14.77 | 128.05 | 14,493.56 | -1,442.46 | -1,712.2 | 486.15 | -637.35 | -518.78 | -189.3 | -994.1 | -1,109.6 | -2,530.6 | -2,553.2 | 1,543.7 | 1,127.708 | -896.057 | 1,876.025 | 2,118.557 | 986.842 | 402.461 |
| Income Before Tax Ratio
| 0.003 | 0.028 | 2.199 | -0.234 | -0.319 | 0.107 | -0.109 | -0.099 | -0.029 | -0.145 | -0.218 | -0.416 | -0.36 | 0.132 | 0.125 | -0.114 | 0.223 | 0.252 | 0.182 | 0.123 |
| Income Tax Expense
| 29.82 | 465.5 | 3,710.22 | 19.57 | 166.4 | 77.07 | 98.58 | -109.8 | 19.2 | 30.8 | 16.8 | -187.6 | -541.9 | 218.9 | 403.6 | -236.133 | 587.041 | 642.108 | 394.376 | 129.544 |
| Net Income
| -11.73 | -332.37 | 10,783.15 | -1,476.96 | -1,942.67 | 377.27 | -739.78 | -562 | -182.9 | -1,065 | -1,121.3 | -2,342.8 | -2,056.6 | 1,446.6 | 724.2 | -659.925 | 1,289.817 | 1,476.449 | 592.467 | 272.916 |
| Net Income Ratio
| -0.002 | -0.072 | 1.636 | -0.239 | -0.362 | 0.083 | -0.126 | -0.107 | -0.028 | -0.155 | -0.22 | -0.385 | -0.29 | 0.124 | 0.08 | -0.084 | 0.153 | 0.175 | 0.109 | 0.083 |
| EPS
| -0.19 | -5.43 | 176.05 | -24.11 | -31.72 | 6.16 | -12.41 | -9.18 | -2.99 | -17.39 | -18.31 | -38.25 | -33.58 | 22.98 | 12.24 | -9.82 | 19.51 | 23.84 | 9.57 | 3.91 |
| EPS Diluted
| -0.19 | -5.43 | 176.05 | -24.11 | -31.72 | 6.16 | -12.41 | -9.18 | -2.99 | -17.39 | -18.31 | -38.25 | -33.58 | 22.98 | 11.46 | -9.26 | 18.25 | 21.85 | 9.36 | 3.91 |
| EBITDA
| 415.37 | 563.65 | 16,739.72 | 865.18 | 456.49 | 2,074.46 | 941.25 | 1,129.74 | 1,813.9 | 648 | 1,104.4 | -840.6 | -774.8 | 2,994.8 | 2,201.7 | 245.484 | 2,494.28 | 2,667.851 | 1,314.116 | 703.196 |
| EBITDA Ratio
| 0.074 | 0.123 | 2.539 | 0.14 | 0.085 | 0.459 | 0.161 | 0.215 | 0.278 | 0.094 | 0.217 | -0.138 | -0.109 | 0.256 | 0.244 | 0.031 | 0.296 | 0.317 | 0.243 | 0.214 |